BioCatalystWatch
SNDXWorkspace / SNDX / OverviewCompany library
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc (SNDX)

Website

Price
Market cap
Next catalystDec 12, 2026revuforj · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

SNDX-4321

Mutant EGFR, including L858R

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

SNDX-62122

Menin

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Menin

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Menin

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Menin

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Menin

PreINDP1P3FilingApproved
Upcoming / outlook

SNDX-4321

Mutant EGFR, including L858R

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

SNDX-62122

Menin

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Niktimvo (axatilimab-csfr)

CSF-1R

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Partner / License out

Approved / commercial

Niktimvo (axatilimab-csfr)

CSF-1R

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

Niktimvo (axatilimab-csfr)

CSF-1R

PreINDP1P2P3FilingApproved
Revuforj® (revumenib)

Menin

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SNDX PR & News

PR & News

SNDX SEC archive